{"transactions":[{"id":1086854,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-16T21:44:25.000Z","date":"2025-07-15","kind":"grant","planned":false,"acquired":true,"shares":164,"price":38.01,"value":6233.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Director equity in lieu of cash retainer program."}],"balance_after":32345,"source":{"system":"sec-edgar","filing":"0001127602-25-019290","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225019290/form4.xml","form_type":"4"}},{"id":1111614,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-13T20:30:12.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":10350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest and become exercisable on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":10350,"derivative":{"exercise_price":32.33,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":10350},"source":{"system":"sec-edgar","filing":"0000950170-25-086260","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000095017025086260/ownership.xml","form_type":"4"}},{"id":1111613,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T20:30:12.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":6900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 100% vesting on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":116146,"source":{"system":"sec-edgar","filing":"0000950170-25-086260","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000095017025086260/ownership.xml","form_type":"4"}},{"id":1149740,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2025-05-14T23:25:35.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":10880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Comprised of stock options that will vest monthly in equal installments over a period commencing on the grant date and ending on the earlier to occur of (x) the one-year anniversary of the date of the grant and (y) the date of the issuer's annual meeting of stockholders for the calendar year immediately subsequent to the grant date, subject to the director's continuous service as a member of the issuer's Board of Directors."}],"balance_after":10880,"derivative":{"exercise_price":30,"exercise_date":"2025-06-16","expiration_date":"2035-05-13","underlying":"Common Stock","underlying_shares":10880},"source":{"system":"sec-edgar","filing":"0001127602-25-014355","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225014355/form4.xml","form_type":"4"}},{"id":1149739,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-14T23:25:35.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":7333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Comprised of restricted stock units (\"RSUs\") that will vest in one installment on the earlier to occur of (x) the one-year anniversary of the grant date and (y) the date of the issuer's annual meeting of stockholders for the calendar year immediately subsequent to the grant date, subject to the director's continuous service as a member of the issuer's Board of Directors. RSUs convert to shares of common stock on a 1:1 basis upon vesting."}],"balance_after":32181,"source":{"system":"sec-edgar","filing":"0001127602-25-014355","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225014355/form4.xml","form_type":"4"}},{"id":1168702,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-21T21:42:08.000Z","date":"2025-04-21","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on May 20, 2016."}],"balance_after":0,"derivative":{"exercise_price":6.21,"exercise_date":"2015-06-22","expiration_date":"2025-05-20","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001127602-25-012398","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225012398/form4.xml","form_type":"4"}},{"id":1168701,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-04-21T21:42:08.000Z","date":"2025-04-21","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":38.46,"value":769200.0,"ownership":{"direct":true},"balance_after":24848,"source":{"system":"sec-edgar","filing":"0001127602-25-012398","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225012398/form4.xml","form_type":"4"}},{"id":1168700,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-04-21T21:42:08.000Z","date":"2025-04-21","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":6.21,"value":124200.0,"ownership":{"direct":true},"balance_after":44848,"source":{"system":"sec-edgar","filing":"0001127602-25-012398","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225012398/form4.xml","form_type":"4"}},{"id":1171209,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-04-16T20:04:02.000Z","date":"2025-04-15","kind":"grant","planned":false,"acquired":true,"shares":162,"price":38.56,"value":6246.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired pursuant to Director Stock in lieu of Cash Retainer Program."}],"balance_after":24848,"source":{"system":"sec-edgar","filing":"0001127602-25-012113","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225012113/form4.xml","form_type":"4"}},{"id":1311566,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-01-06T21:22:15.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":127,"price":48.93,"value":6214.11,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Director Stock in Lieu of Cash Retainer Program"}],"balance_after":24686,"source":{"system":"sec-edgar","filing":"0001127602-25-000758","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225000758/form4.xml","form_type":"4"}},{"id":1331266,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2024-12-17T00:23:03.000Z","date":"2024-12-16","kind":"exercise","planned":true,"acquired":false,"shares":742,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable as to 5,936 shares divided into equal monthly installments such that the option shall be 100% vested on January 2, 2016."}],"balance_after":0,"derivative":{"exercise_price":7.37,"exercise_date":"2015-02-02","expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":742},"source":{"system":"sec-edgar","filing":"0001127602-24-029523","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224029523/form4.xml","form_type":"4"}},{"id":1331265,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-12-17T00:23:03.000Z","date":"2024-12-16","kind":"sale","planned":true,"acquired":false,"shares":742,"price":48.61,"value":36068.62,"ownership":{"direct":true},"balance_after":24559,"source":{"system":"sec-edgar","filing":"0001127602-24-029523","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224029523/form4.xml","form_type":"4"}},{"id":1331264,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-12-17T00:23:03.000Z","date":"2024-12-16","kind":"exercise","planned":true,"acquired":true,"shares":742,"price":7.37,"value":5468.54,"ownership":{"direct":true},"balance_after":25301,"source":{"system":"sec-edgar","filing":"0001127602-24-029523","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224029523/form4.xml","form_type":"4"}},{"id":1351474,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2024-11-26T22:38:48.000Z","date":"2024-11-25","kind":"exercise","planned":true,"acquired":false,"shares":742,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable as to 5,936 shares divided into equal monthly installments such that the option shall be 100% vested on January 2, 2016."}],"balance_after":742,"derivative":{"exercise_price":7.37,"exercise_date":"2015-02-02","expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":742},"source":{"system":"sec-edgar","filing":"0001127602-24-028124","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224028124/form4.xml","form_type":"4"}},{"id":1351473,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-11-26T22:38:48.000Z","date":"2024-11-25","kind":"sale","planned":true,"acquired":false,"shares":742,"price":50,"value":37100.0,"ownership":{"direct":true},"balance_after":24559,"source":{"system":"sec-edgar","filing":"0001127602-24-028124","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224028124/form4.xml","form_type":"4"}},{"id":1351472,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-11-26T22:38:48.000Z","date":"2024-11-25","kind":"exercise","planned":true,"acquired":true,"shares":742,"price":7.37,"value":5468.54,"ownership":{"direct":true},"balance_after":25301,"source":{"system":"sec-edgar","filing":"0001127602-24-028124","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224028124/form4.xml","form_type":"4"}},{"id":1378973,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2024-10-31T20:49:20.000Z","date":"2024-10-28","kind":"exercise","planned":true,"acquired":false,"shares":4452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable as to 5,936 shares divided into equal monthly installments such that the option shall be 100% vested on January 2, 2016."}],"balance_after":1484,"derivative":{"exercise_price":7.37,"exercise_date":"2015-02-02","expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":4452},"source":{"system":"sec-edgar","filing":"0001127602-24-026161","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224026161/form4.xml","form_type":"4"}},{"id":1378972,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-10-31T20:49:20.000Z","date":"2024-10-28","kind":"sale","planned":true,"acquired":false,"shares":4452,"price":52.25,"value":232617.0,"ownership":{"direct":true},"balance_after":24559,"source":{"system":"sec-edgar","filing":"0001127602-24-026161","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224026161/form4.xml","form_type":"4"}},{"id":1378971,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-10-31T20:49:20.000Z","date":"2024-10-28","kind":"exercise","planned":true,"acquired":true,"shares":4452,"price":7.37,"value":32811.24,"ownership":{"direct":true},"balance_after":29011,"source":{"system":"sec-edgar","filing":"0001127602-24-026161","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224026161/form4.xml","form_type":"4"}},{"id":1392516,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-10-03T21:25:33.000Z","date":"2024-10-01","kind":"grant","planned":false,"acquired":true,"shares":118,"price":52.6,"value":6206.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Stock award in lieu of cash retainer payment."}],"balance_after":24559,"source":{"system":"sec-edgar","filing":"0001127602-24-025194","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224025194/form4.xml","form_type":"4"}},{"id":1460775,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-07-04T00:05:55.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":114,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Stock award in lieu of cash retainer payment."}],"balance_after":24441,"source":{"system":"sec-edgar","filing":"0001127602-24-020149","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224020149/form4.xml","form_type":"4"}},{"id":1483423,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-11T20:18:42.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest and become exercisable on the earlier of the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":12500,"derivative":{"exercise_price":44.71,"expiration_date":"2034-06-07","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000950170-24-071921","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000095017024071921/ownership.xml","form_type":"4"}},{"id":1483422,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-11T20:18:42.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":3400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 100% vesting on the earlier of the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":109246,"source":{"system":"sec-edgar","filing":"0000950170-24-071921","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000095017024071921/ownership.xml","form_type":"4"}},{"id":1514783,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2024-05-16T22:00:54.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":3636,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3636,"derivative":{"exercise_price":60.5,"exercise_date":"2024-06-17","expiration_date":"2034-05-15","underlying":"Common Stock","underlying_shares":3636},"source":{"system":"sec-edgar","filing":"0001127602-24-015719","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224015719/form4.xml","form_type":"4"}},{"id":1514782,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-16T22:00:54.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":5600,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":24327,"source":{"system":"sec-edgar","filing":"0001127602-24-015719","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224015719/form4.xml","form_type":"4"}},{"id":1693925,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-01-03T21:27:16.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":74,"price":84.12,"value":6224.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are fully vested from the moment of grant. Shares issued at per share price of $84.12, representing the Issuer's closing stock price on January 2, 2024."}],"balance_after":18727,"source":{"system":"sec-edgar","filing":"0001127602-24-000433","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224000433/form4.xml","form_type":"4"}},{"id":1699701,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2023-12-27T21:11:38.000Z","date":"2023-12-27","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 7, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable as to 10,000 shares divided into equal monthly installments such that the option shall be 100% vested on May 21, 2015."}],"balance_after":0,"derivative":{"exercise_price":4.44,"exercise_date":"2014-06-21","expiration_date":"2024-05-21","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001127602-23-030485","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223030485/form4.xml","form_type":"4"}},{"id":1699700,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2023-12-27T21:11:38.000Z","date":"2023-12-27","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 7, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable as to 10,000 shares divided into equal monthly installments such that the option shall be 100% vested on May 21, 2015."}],"balance_after":5000,"derivative":{"exercise_price":4.44,"exercise_date":"2014-06-21","expiration_date":"2024-05-21","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001127602-23-030485","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223030485/form4.xml","form_type":"4"}},{"id":1699699,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-12-27T21:11:38.000Z","date":"2023-12-27","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":73.6,"value":368000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 7, 2023."}],"balance_after":18653,"source":{"system":"sec-edgar","filing":"0001127602-23-030485","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223030485/form4.xml","form_type":"4"}},{"id":1699698,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-12-27T21:11:38.000Z","date":"2023-12-27","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":4.44,"value":22200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 7, 2023."}],"balance_after":23653,"source":{"system":"sec-edgar","filing":"0001127602-23-030485","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223030485/form4.xml","form_type":"4"}},{"id":1699697,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-12-27T21:11:38.000Z","date":"2023-12-27","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":73.6,"value":368000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 7, 2023."}],"balance_after":18653,"source":{"system":"sec-edgar","filing":"0001127602-23-030485","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223030485/form4.xml","form_type":"4"}},{"id":1699696,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-12-27T21:11:38.000Z","date":"2023-12-27","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":4.44,"value":22200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 7, 2023."}],"balance_after":23653,"source":{"system":"sec-edgar","filing":"0001127602-23-030485","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223030485/form4.xml","form_type":"4"}},{"id":1768486,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-10-03T20:15:18.000Z","date":"2023-10-02","kind":"grant","planned":false,"acquired":true,"shares":448,"price":27.88,"value":12490.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.  Shares are full vested from the moment of grant.  Shares issued at per share price of $27.88, representing the Issuer's closing stock price on October 2, 2023."}],"balance_after":18653,"source":{"system":"sec-edgar","filing":"0001127602-23-025166","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223025166/form4.xml","form_type":"4"}},{"id":1801087,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2023-08-21T20:01:27.000Z","date":"2023-08-21","kind":"exercise","planned":true,"acquired":false,"shares":6020,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":6.72,"exercise_date":"2014-02-02","expiration_date":"2024-01-02","underlying":"Common Stock","underlying_shares":6020},"source":{"system":"sec-edgar","filing":"0001127602-23-023012","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223023012/form4.xml","form_type":"4"}},{"id":1801086,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-21T20:01:27.000Z","date":"2023-08-21","kind":"sale","planned":true,"acquired":false,"shares":6020,"price":32.02,"value":192760.4,"ownership":{"direct":true},"balance_after":18205,"source":{"system":"sec-edgar","filing":"0001127602-23-023012","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223023012/form4.xml","form_type":"4"}},{"id":1801085,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-21T20:01:27.000Z","date":"2023-08-21","kind":"exercise","planned":true,"acquired":true,"shares":6020,"price":6.72,"value":40454.4,"ownership":{"direct":true},"balance_after":24225,"source":{"system":"sec-edgar","filing":"0001127602-23-023012","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223023012/form4.xml","form_type":"4"}},{"id":1837390,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-07-05T20:24:14.000Z","date":"2023-07-03","kind":"grant","planned":false,"acquired":true,"shares":374,"price":33.36,"value":12476.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.  Shares are full vested from the moment of grant.  Shares issued at per share price of $33.36, representing the Issuer's closing stock price on July 3, 2023."}],"balance_after":18205,"source":{"system":"sec-edgar","filing":"0001127602-23-020064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223020064/form4.xml","form_type":"4"}},{"id":1847819,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-21T21:00:37.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest and become exercisable on the earlier of the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":17500,"derivative":{"exercise_price":20.32,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001209191-23-038827","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919123038827/doc4.xml","form_type":"4"}},{"id":1847818,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-21T21:00:37.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 100% vesting on the earlier of the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":105846,"source":{"system":"sec-edgar","filing":"0001209191-23-038827","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919123038827/doc4.xml","form_type":"4"}},{"id":1887372,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2023-05-18T21:13:06.000Z","date":"2023-05-10","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Options shall vest and become exercisable in 12 equal monthly installments, the first such installment vesting on 06/10/2023 and the last such installment vesting on 05/10/2024."}],"balance_after":10000,"derivative":{"exercise_price":37.89,"exercise_date":"2023-06-10","expiration_date":"2033-05-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001127602-23-016196","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223016196/form4.xml","form_type":"4"}},{"id":1887371,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-18T21:13:06.000Z","date":"2023-05-10","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Comprised of restricted stock units that will vest in full and in one installment on 05/10/2024."}],"balance_after":17831,"source":{"system":"sec-edgar","filing":"0001127602-23-016196","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223016196/form4.xml","form_type":"4"}},{"id":1925617,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-04-05T20:04:15.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":298,"price":37.71,"value":11237.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of director's annual base retainer program. Shares are fully vested from the moment of grant. Shares are issued at per share price of $37.71, representing the closing stock price of the Issuer's common stock on April 3, 2023."}],"balance_after":12831,"source":{"system":"sec-edgar","filing":"0001127602-23-012541","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223012541/form4.xml","form_type":"4"}},{"id":2026921,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2023-02-08T21:01:33.000Z","date":"2023-02-06","kind":"exercise","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on November 8, 2022."}],"balance_after":6020,"derivative":{"exercise_price":6.72,"exercise_date":"2014-02-02","expiration_date":"2024-01-02","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001127602-23-003984","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223003984/form4.xml","form_type":"4"}},{"id":2026920,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-02-08T21:01:33.000Z","date":"2023-02-06","kind":"sale","acquired":false,"shares":7000,"price":45,"value":315000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on November 8, 2022."}],"balance_after":12533,"source":{"system":"sec-edgar","filing":"0001127602-23-003984","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223003984/form4.xml","form_type":"4"}},{"id":2026919,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-02-08T21:01:33.000Z","date":"2023-02-06","kind":"exercise","acquired":true,"shares":7000,"price":6.72,"value":47040.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on November 8, 2022."}],"balance_after":19533,"source":{"system":"sec-edgar","filing":"0001127602-23-003984","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223003984/form4.xml","form_type":"4"}},{"id":2069391,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-01-04T23:40:00.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":253,"price":44.35,"value":11220.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.  Shares are full vested from the moment of grant.  Shares issued at per share price of $44.35, representing the Issuer's closing stock price on January 3, 2023."}],"balance_after":12533,"source":{"system":"sec-edgar","filing":"0001127602-23-000714","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223000714/form4.xml","form_type":"4"}},{"id":2142690,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-10-05T20:23:51.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":110,"price":51.11,"value":5622.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are fully vested from the moment of grant. Shares are issued at per share price of $51.11, representing the closing stock price of the Issuer's common stock on October 3, 2022."}],"balance_after":12280,"source":{"system":"sec-edgar","filing":"0001127602-22-023701","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760222023701/form4.xml","form_type":"4"}},{"id":2169241,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2022-09-01T22:19:34.000Z","date":"2022-09-01","kind":"exercise","acquired":false,"shares":4166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on July 1, 2022."}],"balance_after":0,"derivative":{"exercise_price":6.78,"exercise_date":"2013-06-22","expiration_date":"2023-05-22","underlying":"Common Stock","underlying_shares":4166},"source":{"system":"sec-edgar","filing":"0001127602-22-021922","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760222021922/form4.xml","form_type":"4"}},{"id":2169240,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-09-01T22:19:34.000Z","date":"2022-09-01","kind":"sale","acquired":false,"shares":4166,"price":52.79,"value":219923.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on July 1, 2022."}],"balance_after":12170,"source":{"system":"sec-edgar","filing":"0001127602-22-021922","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760222021922/form4.xml","form_type":"4"}},{"id":2169239,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-09-01T22:19:34.000Z","date":"2022-09-01","kind":"exercise","acquired":true,"shares":4166,"price":6.78,"value":28245.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on July 1, 2022."}],"balance_after":16336,"source":{"system":"sec-edgar","filing":"0001127602-22-021922","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760222021922/form4.xml","form_type":"4"}},{"id":2208738,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-07-12T20:37:05.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":137,"price":41,"value":5617.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are fully vested from the moment of grant. Shares are issued at per share price of $41.00, representing the closing stock price of the Issuer's common stock on July 1, 2022."}],"balance_after":12170,"source":{"system":"sec-edgar","filing":"0001127602-22-019241","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760222019241/form4.xml","form_type":"4"}},{"id":2225438,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-21T20:48:19.000Z","date":"2022-06-17","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The entire number of shares subject to this option become fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":17500,"derivative":{"exercise_price":18.29,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001209191-22-038442","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919122038442/doc4.xml","form_type":"4"}},{"id":2275153,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-05-11T22:07:01.000Z","date":"2022-05-10","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options shall vest and become exercisable in 12 equal monthly installments, the first such installment vesting on 06/10/2022 and the last such installment vesting on 05/10/2023."}],"balance_after":10000,"derivative":{"exercise_price":37.89,"expiration_date":"2032-05-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001061983-22-000122","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000122/edgardoc.xml","form_type":"4"}},{"id":2275152,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-11T22:07:01.000Z","date":"2022-05-10","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Comprised of restricted stock units that will vest in full and in one installment on 05/10/2023."}],"balance_after":12033,"source":{"system":"sec-edgar","filing":"0001061983-22-000122","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000122/edgardoc.xml","form_type":"4"}},{"id":2311676,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-01T23:17:53.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":146,"price":38.38,"value":5603.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are fully vested from the moment of grant. Shares issued at per share price of $38.38, representing the Issuer's closing stock price on April 1, 2022."}],"balance_after":7033,"source":{"system":"sec-edgar","filing":"0001061983-22-000090","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000090/edgardoc.xml","form_type":"4"}},{"id":2450728,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-04T21:48:22.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":122,"price":46,"value":5612.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are full vested from the moment of grant. Shares issued at per share price of $46.00, representing the Issuer's closing stock price on January 3, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 1,887 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":6887,"source":{"system":"sec-edgar","filing":"0001061983-22-000013","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000013/edgardoc.xml","form_type":"4"}},{"id":2458040,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-12-28T22:16:51.000Z","date":"2021-12-27","kind":"exercise","acquired":false,"shares":4166,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":5.46,"exercise_date":"2012-06-22","expiration_date":"2022-05-22","underlying":"Common Stock","underlying_shares":4166},"source":{"system":"sec-edgar","filing":"0001061983-21-000269","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000269/edgardoc.xml","form_type":"4"}},{"id":2458039,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-28T22:16:51.000Z","date":"2021-12-27","kind":"sale","acquired":false,"shares":4166,"price":44.3721,"value":184854.1686,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on November 24, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":6765,"source":{"system":"sec-edgar","filing":"0001061983-21-000269","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000269/edgardoc.xml","form_type":"4"}},{"id":2458038,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-28T22:16:51.000Z","date":"2021-12-27","kind":"exercise","acquired":true,"shares":4166,"price":5.46,"value":22746.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on November 24, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":10931,"source":{"system":"sec-edgar","filing":"0001061983-21-000269","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000269/edgardoc.xml","form_type":"4"}},{"id":2552747,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-04T23:03:37.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":306,"price":36.74,"value":11242.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.  Shares are full vested from the moment of grant.  Shares issued at per share price of $36.74, representing the Issuer's closing stock price on October 1, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":6765,"source":{"system":"sec-edgar","filing":"0001061983-21-000232","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000232/edgardoc.xml","form_type":"4"}},{"id":2638675,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-08T21:32:54.000Z","date":"2021-07-07","kind":"grant","acquired":true,"shares":63,"price":19.77,"value":1245.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.  Shares are full vested from the moment of grant.  Shares issued at per share price of $19.77, representing the Issuer's closing stock price on July 7, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 1,459 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":6459,"source":{"system":"sec-edgar","filing":"0001061983-21-000194","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000194/edgardoc.xml","form_type":"4"}},{"id":2645664,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-02T20:44:42.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":476,"price":20.98,"value":9986.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.  Shares are full vested from the moment of grant.  Shares issued at per share price of $20.98, representing the Issuer's closing stock price on July 1, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 1,396 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":6396,"source":{"system":"sec-edgar","filing":"0001061983-21-000170","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000170/edgardoc.xml","form_type":"4"}},{"id":2657099,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-23T21:00:30.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The entire number of shares subject to this option become fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":17500,"derivative":{"exercise_price":20.23,"expiration_date":"2031-06-21","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001209191-21-042769","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919121042769/doc4.xml","form_type":"4"}},{"id":2714994,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-05-14T00:04:14.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options shall vest and become exercisable in 12 equal monthly installments, the first such installment vesting on 06/12/2021 and the last such installment vesting on 05/12/2022."}],"balance_after":10000,"derivative":{"exercise_price":24.32,"exercise_date":"2021-06-12","expiration_date":"2031-05-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001061983-21-000145","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000145/edgardoc.xml","form_type":"4"}},{"id":2714993,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-14T00:04:14.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Comprised of restricted stock units that will vest in full and in one installment on 05/12/2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 920 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":5920,"source":{"system":"sec-edgar","filing":"0001061983-21-000145","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000145/edgardoc.xml","form_type":"4"}},{"id":2758719,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-05T21:48:24.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":409,"price":24.44,"value":9995.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.  Shares are full vested from the moment of grant.  Shares issued at per share price of $24.44, representing the Issuer's closing stock price on April 1, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 920 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":920,"source":{"system":"sec-edgar","filing":"0001061983-21-000100","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000100/edgardoc.xml","form_type":"4"}},{"id":2922129,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T23:19:01.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":511,"price":19.56,"value":9995.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.  Shares are full vested from the moment of grant.  Shares issued at per share price of $19.56, representing the Issuer's closing stock price on January 4, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 511 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":511,"source":{"system":"sec-edgar","filing":"0001061983-21-000017","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000017/edgardoc.xml","form_type":"4"}},{"id":3103146,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-22T20:17:34.000Z","date":"2020-06-19","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The entire number of shares subject to this option become fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":12500,"derivative":{"exercise_price":23.23,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-20-038153","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919120038153/doc4.xml","form_type":"4"}},{"id":3149426,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-05-14T20:46:38.000Z","date":"2020-05-13","kind":"grant","acquired":true,"shares":20000,"price":21.61,"value":432200.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest and become exercisable in 12 equal monthly installments as from the date of the grant."}],"balance_after":20000,"derivative":{"exercise_price":21.61,"expiration_date":"2030-05-13","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001061983-20-000093","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000093/edgardoc.xml","form_type":"4"}},{"id":3167618,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-04-29T22:25:45.000Z","date":"2020-04-28","kind":"exercise","acquired":false,"shares":6666,"price":16,"value":106656.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":11.04,"exercise_date":"2011-03-09","expiration_date":"2021-02-09","underlying":"Common Stock","underlying_shares":6666},"source":{"system":"sec-edgar","filing":"0001061983-20-000071","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000071/edgardoc.xml","form_type":"4"}},{"id":3167617,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-04-29T22:25:45.000Z","date":"2020-04-28","kind":"exercise","acquired":false,"shares":3333,"price":16,"value":53328.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":8.64,"exercise_date":"2011-06-18","expiration_date":"2021-05-18","underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001061983-20-000071","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000071/edgardoc.xml","form_type":"4"}},{"id":3167616,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-29T22:25:45.000Z","date":"2020-04-28","kind":"sale","acquired":false,"shares":6666,"price":16,"value":106656.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001061983-20-000071","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000071/edgardoc.xml","form_type":"4"}},{"id":3167615,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-29T22:25:45.000Z","date":"2020-04-28","kind":"exercise","acquired":true,"shares":6666,"price":11.04,"value":73592.64,"ownership":{"direct":true},"balance_after":6666,"source":{"system":"sec-edgar","filing":"0001061983-20-000071","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000071/edgardoc.xml","form_type":"4"}},{"id":3167614,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-29T22:25:45.000Z","date":"2020-04-28","kind":"sale","acquired":false,"shares":3333,"price":16,"value":53328.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001061983-20-000071","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000071/edgardoc.xml","form_type":"4"}},{"id":3167613,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-29T22:25:45.000Z","date":"2020-04-28","kind":"exercise","acquired":true,"shares":3333,"price":8.64,"value":28797.12,"ownership":{"direct":true},"balance_after":3333,"source":{"system":"sec-edgar","filing":"0001061983-20-000071","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000071/edgardoc.xml","form_type":"4"}},{"id":3167438,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to but)","published_at":"2020-04-29T21:01:32.000Z","date":"2020-04-28","kind":"exercise","acquired":false,"shares":25329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vested on October 30, 2016, and 1/48th of the shares subject to the option vested monthly thereafter such that all of the shares subject to the option were fully vested as of October 30, 2019."}],"balance_after":12500,"derivative":{"exercise_price":0.73,"expiration_date":"2025-12-10","underlying":"Common Stock","underlying_shares":25329},"source":{"system":"sec-edgar","filing":"0001209191-20-026196","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919120026196/doc4.xml","form_type":"4"}},{"id":3167437,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-29T21:01:32.000Z","date":"2020-04-28","kind":"exercise","acquired":true,"shares":25329,"price":0.73,"value":18490.17,"ownership":{"direct":true},"balance_after":99846,"source":{"system":"sec-edgar","filing":"0001209191-20-026196","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919120026196/doc4.xml","form_type":"4"}},{"id":3478733,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-25T20:07:04.000Z","date":"2019-06-21","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The entire number of shares subject to this option become fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date."}],"balance_after":12500,"derivative":{"exercise_price":23.24,"expiration_date":"2029-06-20","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-19-038894","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658247/000120919119038894/doc4.xml","form_type":"4"}},{"id":3521910,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-05-17T21:10:00.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":20000,"price":10.68,"value":213600.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on May 15, 2020"}],"balance_after":20000,"derivative":{"exercise_price":10.68,"expiration_date":"2029-05-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001061983-19-000040","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198319000040/edgardoc.xml","form_type":"4"}},{"id":3890472,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (Right to Buy)","published_at":"2018-06-18T19:00:42.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in equal quarterly installments over a one-year period, through and including June 14, 2019."}],"balance_after":10000,"derivative":{"exercise_price":19.59,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-18-017080","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235945/000089924318017080/doc4.xml","form_type":"4"}},{"id":3928859,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-05-17T22:29:50.000Z","date":"2018-05-16","kind":"grant","acquired":true,"shares":20000,"price":9.45,"value":189000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on May 16, 2019"}],"balance_after":20000,"derivative":{"exercise_price":9.45,"expiration_date":"2028-05-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001061983-18-000031","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000031/edgardoc.xml","form_type":"4"}},{"id":4104558,"issuer":{"id":93662,"kind":"organization","name":"SEELOS THERAPEUTICS, INC.","symbol":"SEEL"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-01-08T16:03:09.000Z","date":"2018-01-04","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The options to purchase shares of common stock were issued to the Reporting Person, a non-employee director of Issuer, as an annual stock option grant for his service as a director of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options shall vest with respect to 1/12th of the underlying shares monthly, commencing with the first monthly vesting date of February 4, 2018, so that such options are fully vested on January 4, 2019."}],"balance_after":35000,"derivative":{"exercise_price":2.11,"expiration_date":"2028-01-04","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001017491-18-000018","document":"wf-form4_151544537580041.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1017491/000101749118000018/wf-form4_151544537580041.xml","form_type":"4"}},{"id":4108355,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-01-04T23:37:05.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":5714,"price":3.5002,"value":20000.1428,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was issued to the reporting person pursuant to the Cytokinetics 2004 Equity Incentive Plan in lieu of 50% of an annual retainer of $40,000.00"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable as to 5,714 shares divided into equal monthly installments such that the option shall be 100% vested on January 2, 2019."}],"balance_after":5714,"derivative":{"exercise_price":8.75,"exercise_date":"2018-02-02","expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":5714},"source":{"system":"sec-edgar","filing":"0001061983-18-000006","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198318000006/edgardoc.xml","form_type":"4"}},{"id":4136214,"issuer":{"id":171193,"kind":"organization","name":"Ocera Therapeutics, Inc.","symbol":"OCRX"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-11T15:18:53.000Z","date":"2017-12-11","kind":"disposition_to_issuer","acquired":false,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, each option to purchase a share of the Issuer's common stock outstanding and unexercised immediately prior to the Effective Time, whether or not vested and which had a per-share exercise price of less than the $1.52 (each, an \"In the Money Option\") was canceled and converted into the right of the holder of such In the Money Company Stock Option to receive, for each Share underlying such In the Money Company Stock Option, (i) an amount in cash, without interest and subject to deduction for any required withholding taxes, equal to the excess, if any, of $1.52 over the applicable exercise price for such Share, plus (ii) one CVR."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"(Continued from Footnote 4) All other options (each, an \"Out of the Money Option\") that were outstanding and unexercised and whether or not vested, were canceled and converted into the right to receive one or more cash payments, if any, at each Milestone Payment Date (as defined in the CVR Agreement) equal to (i) the amount by which the Per Share Value Paid (as defined in the Merger Agreement) exceeds the exercise price payable per Share subject to such Out of the Money Option, less (ii) the amount of all payments previously paid with respect to such Out of the Money Option.  Any Out of the Money Option with an exercise price per Share equal to or greater than $4.10 was cancelled without any consideration payable therefore."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This Out of the Money Option, which became fully vested on June 14, 2017, was cancelled in connection with the Merger in exchange for the right to receive one or more cash payments, without interest and subject to deduction for any required withholding taxes, equal to (i) the amount by which the Per Share Value Paid (as defined in the Merger Agreement) exceeds $2.26, less (ii) the amount of all payments previously paid with respect to such Out of the Money Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, each option to purchase a share of the Issuer's common stock outstanding and unexercised immediately prior to the Effective Time, whether or not vested and which had a per-share exercise price of less than the $1.52 (each, an \"In the Money Option\") was canceled and converted into the right of the holder of such In the Money Company Stock Option to receive, for each Share underlying such In the Money Company Stock Option, (i) an amount in cash, without interest and subject to deduction for any required withholding taxes, equal to the excess, if any, of $1.52 over the applicable exercise price for such Share, plus (ii) one CVR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"(Continued from Footnote 4) All other options (each, an \"Out of the Money Option\") that were outstanding and unexercised and whether or not vested, were canceled and converted into the right to receive one or more cash payments, if any, at each Milestone Payment Date (as defined in the CVR Agreement) equal to (i) the amount by which the Per Share Value Paid (as defined in the Merger Agreement) exceeds the exercise price payable per Share subject to such Out of the Money Option, less (ii) the amount of all payments previously paid with respect to such Out of the Money Option.  Any Out of the Money Option with an exercise price per Share equal to or greater than $4.10 was cancelled without any consideration payable therefore."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"This Out of the Money Option, which became fully vested on June 14, 2017, was cancelled in connection with the Merger in exchange for the right to receive one or more cash payments, without interest and subject to deduction for any required withholding taxes, equal to (i) the amount by which the Per Share Value Paid (as defined in the Merger Agreement) exceeds $2.26, less (ii) the amount of all payments previously paid with respect to such Out of the Money Option."}],"balance_after":0,"derivative":{"exercise_price":2.26,"expiration_date":"2026-06-13","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000899243-17-028411","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1274644/000089924317028411/doc4.xml","form_type":"4"}},{"id":4136213,"issuer":{"id":171193,"kind":"organization","name":"Ocera Therapeutics, Inc.","symbol":"OCRX"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-11T15:18:53.000Z","date":"2017-12-11","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, each option to purchase a share of the Issuer's common stock outstanding and unexercised immediately prior to the Effective Time, whether or not vested and which had a per-share exercise price of less than the $1.52 (each, an \"In the Money Option\") was canceled and converted into the right of the holder of such In the Money Company Stock Option to receive, for each Share underlying such In the Money Company Stock Option, (i) an amount in cash, without interest and subject to deduction for any required withholding taxes, equal to the excess, if any, of $1.52 over the applicable exercise price for such Share, plus (ii) one CVR."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"(Continued from Footnote 4) All other options (each, an \"Out of the Money Option\") that were outstanding and unexercised and whether or not vested, were canceled and converted into the right to receive one or more cash payments, if any, at each Milestone Payment Date (as defined in the CVR Agreement) equal to (i) the amount by which the Per Share Value Paid (as defined in the Merger Agreement) exceeds the exercise price payable per Share subject to such Out of the Money Option, less (ii) the amount of all payments previously paid with respect to such Out of the Money Option.  Any Out of the Money Option with an exercise price per Share equal to or greater than $4.10 was cancelled without any consideration payable therefore."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This Out of the Money Option, which became fully vested on June 18, 2016, was cancelled in connection with the Merger in exchange for the right to receive one or more cash payments, without interest and subject to deduction for any required withholding taxes, equal to (i) the amount by which the Per Share Value Paid (as defined in the Merger Agreement) exceeds $3.76, less (ii) the amount of all payments previously paid with respect to such Out of the Money Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, each option to purchase a share of the Issuer's common stock outstanding and unexercised immediately prior to the Effective Time, whether or not vested and which had a per-share exercise price of less than the $1.52 (each, an \"In the Money Option\") was canceled and converted into the right of the holder of such In the Money Company Stock Option to receive, for each Share underlying such In the Money Company Stock Option, (i) an amount in cash, without interest and subject to deduction for any required withholding taxes, equal to the excess, if any, of $1.52 over the applicable exercise price for such Share, plus (ii) one CVR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"(Continued from Footnote 4) All other options (each, an \"Out of the Money Option\") that were outstanding and unexercised and whether or not vested, were canceled and converted into the right to receive one or more cash payments, if any, at each Milestone Payment Date (as defined in the CVR Agreement) equal to (i) the amount by which the Per Share Value Paid (as defined in the Merger Agreement) exceeds the exercise price payable per Share subject to such Out of the Money Option, less (ii) the amount of all payments previously paid with respect to such Out of the Money Option.  Any Out of the Money Option with an exercise price per Share equal to or greater than $4.10 was cancelled without any consideration payable therefore."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This Out of the Money Option, which became fully vested on June 18, 2016, was cancelled in connection with the Merger in exchange for the right to receive one or more cash payments, without interest and subject to deduction for any required withholding taxes, equal to (i) the amount by which the Per Share Value Paid (as defined in the Merger Agreement) exceeds $3.76, less (ii) the amount of all payments previously paid with respect to such Out of the Money Option."}],"balance_after":0,"derivative":{"exercise_price":3.76,"expiration_date":"2025-06-17","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-17-028411","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1274644/000089924317028411/doc4.xml","form_type":"4"}},{"id":4136212,"issuer":{"id":171193,"kind":"organization","name":"Ocera Therapeutics, Inc.","symbol":"OCRX"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-11T15:18:53.000Z","date":"2017-12-11","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, each option to purchase a share of the Issuer's common stock outstanding and unexercised immediately prior to the Effective Time, whether or not vested and which had a per-share exercise price of less than the $1.52 (each, an \"In the Money Option\") was canceled and converted into the right of the holder of such In the Money Company Stock Option to receive, for each Share underlying such In the Money Company Stock Option, (i) an amount in cash, without interest and subject to deduction for any required withholding taxes, equal to the excess, if any, of $1.52 over the applicable exercise price for such Share, plus (ii) one CVR."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"(Continued from Footnote 4) All other options (each, an \"Out of the Money Option\") that were outstanding and unexercised and whether or not vested, were canceled and converted into the right to receive one or more cash payments, if any, at each Milestone Payment Date (as defined in the CVR Agreement) equal to (i) the amount by which the Per Share Value Paid (as defined in the Merger Agreement) exceeds the exercise price payable per Share subject to such Out of the Money Option, less (ii) the amount of all payments previously paid with respect to such Out of the Money Option.  Any Out of the Money Option with an exercise price per Share equal to or greater than $4.10 was cancelled without any consideration payable therefore."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This Out of the Money Option, which became fully vested on July 11, 2015, was cancelled in connection with the Merge for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, each option to purchase a share of the Issuer's common stock outstanding and unexercised immediately prior to the Effective Time, whether or not vested and which had a per-share exercise price of less than the $1.52 (each, an \"In the Money Option\") was canceled and converted into the right of the holder of such In the Money Company Stock Option to receive, for each Share underlying such In the Money Company Stock Option, (i) an amount in cash, without interest and subject to deduction for any required withholding taxes, equal to the excess, if any, of $1.52 over the applicable exercise price for such Share, plus (ii) one CVR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"(Continued from Footnote 4) All other options (each, an \"Out of the Money Option\") that were outstanding and unexercised and whether or not vested, were canceled and converted into the right to receive one or more cash payments, if any, at each Milestone Payment Date (as defined in the CVR Agreement) equal to (i) the amount by which the Per Share Value Paid (as defined in the Merger Agreement) exceeds the exercise price payable per Share subject to such Out of the Money Option, less (ii) the amount of all payments previously paid with respect to such Out of the Money Option.  Any Out of the Money Option with an exercise price per Share equal to or greater than $4.10 was cancelled without any consideration payable therefore."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This Out of the Money Option, which became fully vested on July 11, 2015, was cancelled in connection with the Merge for no consideration."}],"balance_after":0,"derivative":{"exercise_price":7.84,"expiration_date":"2024-06-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-17-028411","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1274644/000089924317028411/doc4.xml","form_type":"4"}},{"id":4136211,"issuer":{"id":171193,"kind":"organization","name":"Ocera Therapeutics, Inc.","symbol":"OCRX"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-11T15:18:53.000Z","date":"2017-12-11","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, each option to purchase a share of the Issuer's common stock outstanding and unexercised immediately prior to the Effective Time, whether or not vested and which had a per-share exercise price of less than the $1.52 (each, an \"In the Money Option\") was canceled and converted into the right of the holder of such In the Money Company Stock Option to receive, for each Share underlying such In the Money Company Stock Option, (i) an amount in cash, without interest and subject to deduction for any required withholding taxes, equal to the excess, if any, of $1.52 over the applicable exercise price for such Share, plus (ii) one CVR."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"(Continued from Footnote 4) All other options (each, an \"Out of the Money Option\") that were outstanding and unexercised and whether or not vested, were canceled and converted into the right to receive one or more cash payments, if any, at each Milestone Payment Date (as defined in the CVR Agreement) equal to (i) the amount by which the Per Share Value Paid (as defined in the Merger Agreement) exceeds the exercise price payable per Share subject to such Out of the Money Option, less (ii) the amount of all payments previously paid with respect to such Out of the Money Option.  Any Out of the Money Option with an exercise price per Share equal to or greater than $4.10 was cancelled without any consideration payable therefore."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This Out of the Money Option, which provided for vesting with respect to 25% of such options on December 19, 2014, with the remaining 75% of such options vesting in equal monthly installments over the next succeeding three year period, was cancelled in connection with the Merger for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, each option to purchase a share of the Issuer's common stock outstanding and unexercised immediately prior to the Effective Time, whether or not vested and which had a per-share exercise price of less than the $1.52 (each, an \"In the Money Option\") was canceled and converted into the right of the holder of such In the Money Company Stock Option to receive, for each Share underlying such In the Money Company Stock Option, (i) an amount in cash, without interest and subject to deduction for any required withholding taxes, equal to the excess, if any, of $1.52 over the applicable exercise price for such Share, plus (ii) one CVR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"(Continued from Footnote 4) All other options (each, an \"Out of the Money Option\") that were outstanding and unexercised and whether or not vested, were canceled and converted into the right to receive one or more cash payments, if any, at each Milestone Payment Date (as defined in the CVR Agreement) equal to (i) the amount by which the Per Share Value Paid (as defined in the Merger Agreement) exceeds the exercise price payable per Share subject to such Out of the Money Option, less (ii) the amount of all payments previously paid with respect to such Out of the Money Option.  Any Out of the Money Option with an exercise price per Share equal to or greater than $4.10 was cancelled without any consideration payable therefore."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This Out of the Money Option, which provided for vesting with respect to 25% of such options on December 19, 2014, with the remaining 75% of such options vesting in equal monthly installments over the next succeeding three year period, was cancelled in connection with the Merger for no consideration."}],"balance_after":0,"derivative":{"exercise_price":13.25,"expiration_date":"2023-12-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-17-028411","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1274644/000089924317028411/doc4.xml","form_type":"4"}},{"id":4136210,"issuer":{"id":171193,"kind":"organization","name":"Ocera Therapeutics, Inc.","symbol":"OCRX"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-11T15:18:53.000Z","date":"2017-12-11","kind":"disposition_to_issuer","acquired":false,"shares":12500,"price":1.52,"value":19000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to an Agreement and Plan of Merger, dated November 1, 2017 (the \"Merger Agreement\"), by and between Ocera Therapeutics, Inc., a Delaware corporation (the \"Issuer\"),  MAK LLC, a Delaware limited liability company (\"Parent\"), MEH Acquisition Co., a Delaware corporation and a direct wholly-owned subsidiary of Parent (\"Purchaser\"), and for limited purposes, Mallinckrodt plc, an Irish public limited company and the ultimate parent entity of Parent and Purchaser (\"Mallinckrodt\"), Purchaser was merged with and into Issuer on December 11, 2017, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) Pursuant to the terms of the Merger Agreement, all shares of common stock, $0.00001 par value per share (the \"Shares\"), of the Issuer outstanding immediately prior to the effective time of the Merger (the \"Effective Time\") , were canceled and converted automatically and without any required action on the part of the Reporting Person into the right to receive (i) $1.52 per Share in cash, without interest, plus (ii) one non-transferable contingent value right per Share (each, a \"CVR\"), which represents the contractual right under a contingent value rights agreement, by and among Parent, Continental Stock Transfer & Trust Company, and for limited purposes, Mallinckrodt (the \"CVR Agreement\"), entered  into on December 7, 2017  to receive one or more payments in cash currently estimated to be up to $2.58 per Share, contingent upon the achievement of certain milestones, in each case, less any required withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time of the Merger, each restricted stock unit outstanding, automatically and without any required action on the part of the Reporting Person, became fully vested and canceled in exchange for a right to receive, for each share of common stock underlying the restricted stock unit, (i) an amount in cash, equal to $1.52, without interest plus (ii) one CVR, less any required withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-17-028411","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1274644/000089924317028411/doc4.xml","form_type":"4"}},{"id":4136209,"issuer":{"id":171193,"kind":"organization","name":"Ocera Therapeutics, Inc.","symbol":"OCRX"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-11T15:18:53.000Z","date":"2017-12-11","kind":"disposition_to_issuer","acquired":false,"shares":5000,"price":1.52,"value":7600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to an Agreement and Plan of Merger, dated November 1, 2017 (the \"Merger Agreement\"), by and between Ocera Therapeutics, Inc., a Delaware corporation (the \"Issuer\"),  MAK LLC, a Delaware limited liability company (\"Parent\"), MEH Acquisition Co., a Delaware corporation and a direct wholly-owned subsidiary of Parent (\"Purchaser\"), and for limited purposes, Mallinckrodt plc, an Irish public limited company and the ultimate parent entity of Parent and Purchaser (\"Mallinckrodt\"), Purchaser was merged with and into Issuer on December 11, 2017, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) Pursuant to the terms of the Merger Agreement, all shares of common stock, $0.00001 par value per share (the \"Shares\"), of the Issuer outstanding immediately prior to the effective time of the Merger (the \"Effective Time\") , were canceled and converted automatically and without any required action on the part of the Reporting Person into the right to receive (i) $1.52 per Share in cash, without interest, plus (ii) one non-transferable contingent value right per Share (each, a \"CVR\"), which represents the contractual right under a contingent value rights agreement, by and among Parent, Continental Stock Transfer & Trust Company, and for limited purposes, Mallinckrodt (the \"CVR Agreement\"), entered  into on December 7, 2017  to receive one or more payments in cash currently estimated to be up to $2.58 per Share, contingent upon the achievement of certain milestones, in each case, less any required withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-17-028411","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274644/000089924317028411/doc4.xml","form_type":"4"}},{"id":4274428,"issuer":{"id":171193,"kind":"organization","name":"Ocera Therapeutics, Inc.","symbol":"OCRX"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-22T16:42:08.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units shall vest in full on the earlier of the one year anniversary of the grant or the next annual meeting of shareholders; provided, in all cases, that the Reporting Person is, as of each such vesting date, then a director of the Issuer."}],"balance_after":17500,"source":{"system":"sec-edgar","filing":"0001274644-17-000060","document":"wf-form4_149816410200456.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274644/000127464417000060/wf-form4_149816410200456.xml","form_type":"4"}},{"id":4277253,"issuer":{"id":115906,"kind":"organization","name":"CONCERT PHARMACEUTICALS, INC.","symbol":"CNCE"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2017-06-19T07:35:27.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in equal quarterly installments over a one-year period, through and including June 15, 2018."}],"balance_after":10000,"derivative":{"exercise_price":13.29,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-040710","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235945/000120919117040710/doc4.xml","form_type":"4"}},{"id":4310386,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-05-22T21:57:16.000Z","date":"2017-05-18","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on May 18, 2018."}],"balance_after":20000,"derivative":{"exercise_price":14.25,"exercise_date":"2017-06-18","expiration_date":"2027-05-18","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001061983-17-000035","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000035/edgardoc.xml","form_type":"4"}},{"id":4496832,"issuer":{"id":93662,"kind":"organization","name":"SEELOS THERAPEUTICS, INC.","symbol":"SEEL"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-06T19:30:49.000Z","date":"2017-01-05","kind":"grant","acquired":true,"shares":11250,"ownership":{"direct":false,"nature":"Wierenga Family Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (\"RSUs\") were issued to the Reporting Person, a non-employee director of the Issuer, as an annual equity grant for his service as a director of the Issuer. Such RSUs shall fully vest on the first anniversary of the grant date, January 5, 2018, and are subject to accelerated vesting upon a change of control of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":15373,"source":{"system":"sec-edgar","filing":"0001017491-17-000016","document":"wf-form4_148374903696025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1017491/000101749117000016/wf-form4_148374903696025.xml","form_type":"4"}},{"id":4503845,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-01-04T23:47:58.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":4032,"price":4.9603,"value":19999.9296,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was issued to the reporting person pursuant to the Cytokinetics 2004 Equity Incentive Plan in lieu of 50% of an annual retainer of $40,000.00"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable as to 4,032 shares divided into equal monthly installments such that the option shall be 100% vested on January 3, 2018."}],"balance_after":4032,"derivative":{"exercise_price":12.4,"exercise_date":"2017-02-03","expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":4032},"source":{"system":"sec-edgar","filing":"0001061983-17-000010","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198317000010/edgardoc.xml","form_type":"4"}},{"id":4590709,"issuer":{"id":93662,"kind":"organization","name":"SEELOS THERAPEUTICS, INC.","symbol":"SEEL"},"owners":[{"id":77487,"kind":"person","name":"WIERENGA WENDALL","position":1,"cik":"0001235945","reported_name":"WIERENGA WENDALL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-03T16:33:41.000Z","date":"2016-09-30","kind":"grant","acquired":true,"shares":8868,"price":0.3383,"value":3000.0444,"ownership":{"direct":false,"nature":"Wierenga Family Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock were issued to the Reporting Person, a non-employee director of the Issuer, as partial payment for the quarterly retainer fee for his service as director of Issuer under an amended director compensation policy, which reduced the cash compensation payable to the Issuer's non-employee directors and in lieu of such cash compensation, resolved to grant shares of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The value of the shares being delivered in satisfaction of the payment was calculated based on the closing price of the Issuer's common stock on September 30, 2016."}],"balance_after":41228,"source":{"system":"sec-edgar","filing":"0001017491-16-000221","document":"wf-form4_147552680866260.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1017491/000101749116000221/wf-form4_147552680866260.xml","form_type":"4"}}]}